Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases including Alzheimer's and Parkinson's.

Muna Therapeutics

Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. 

Muna discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe. 

We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases.  Our name reflects this focus:  Muna means ‘to remember’ in Old Norse. 

Michael J. Fox Foundation

Sanofi Ventures

Novo Holdings

Polaris Partners

Droia Ventures

Sofinnova Partners

LS Polaris Innovation Fund

LSP BioVentures

V-Bio Ventures

We are recruiting for two Research Associates to join #Muna_Therapeutics' MiND-MAP team in #Leuven, #Belgium.  MiND-MAP is our innovative, all-in-human drug target discovery and validation platform.  MiND-MAP utilizes spatial transcriptomics from postmortem brain samples to understand cellular and molecular responses to misfolded protein and other pathologies and advance these insights into novel drug targets. The role description and how to apply are in the document below. #muna_tx #neurodegeneration #neuroinflammation #Alzheimers #biotech

I am presenting new insights into Kv1.3 blockers as therapeutics for #Parkinson’s and progressive #MS (poster #445) and the impact of MiND-MAP (#151), Muna Therapeutics  all-in-human #alzheimers target mining and validation platform, at #ADPD2024. Also visit our poster on TREM2 agonists (#147)

CEOs of some of the hottest and most innovative companies in CNS Neuroscience drug development are speaking at Bio-Neuroscience. Join them at the summit for leading CEOs, investors and industry. #BioNeuroscience bio-neuroscience.com Niels Plath Muna Therapeutics Broadreach Global Amsterdam UMC Amsterdam UMC - Amsterdam Neuroscience Andrea Soto Padilla Pieter van Bokhoven Paweł Świeboda Naomi Glover, MSc, FRSA, FRSPH European Brain Council

Niels Plath, Muna Tx’s CSO, will be speaking about our work on next generation therapeutics for neurodegenerative diseases at Bio-Neuroscience in Amsterdam.

As we advance our work to the clinic to bring patients therapeutic options for #neurodegenerativediseases, we at Muna Therapeutics have serious fun, every day - check out the video clip below! #muna_tx #neuroscience #neurodegeneration  #alzheimersdisease #parkinsonsdisease #multiplesclerosis #biotech #neurology

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 29, 2024 8:20 PM	50edccc5
public peers	general	Jul 29, 2024 3:49 AM	fb8f214a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 29, 2024 8:29 AM	108dca0e
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	4b97f4db
crunchbase profile	general
li profile	general	Jul 29, 2024 3:49 AM	6e21c21b
translate crunchbase fundingrounds	general
peers	general	Jul 29, 2024 3:49 AM	81bb9c0c
news basic	general	Jul 29, 2024 3:49 AM	7b322af6
bundesanzeiger	filings
financials download nd	financials
private financials	financials

MUNA

COM:MUNATHERAPEUTICS

Muna Therapeutics